Grace Therapeutics (GRCE) Q1 2025 Earnings

13FebConfirmed
Q3 2024
Q4 2024
Q1 2025
-0.37
-0.33
-0.28
-0.24

Details

Expected EPS
-0.335
Actual EPS
-0.36
Surprise EPS
-0.02
Surprise Percent
+7.46%

Description

Grace Therapeutics (GRCE) has reported earnings of -0.36 per share for Q1 2025.

0 Comments

Share your thoughts